Evidence map›Paper›PMID 38291538›Full record

ArticleCell & bioscience2024

CRISPR/Cas9 mediated Y-chromosome elimination affects human cells transcriptome.

Ludovica Celli, Patrizia Gasparini, Ginevra Biino, Laura Zannini, Miriana Cardano

Open access · goldAbstract read
In one paragraph

Article in Cell & bioscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Sex differences in disease: sex chromosome and immunity.Journal of translational medicine · 2024
    Review
  10. Toward DNA-Based Recording of Biological Processes.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ludovica CelliIstituto di Genetica Molecolare "Luigi Luca Cavalli-Sforza", CNR, 27100, Pavia, Italy.
Patrizia GaspariniEpigenomic and Biomarkers of Solid Tumors, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.
Ginevra BiinoIstituto di Genetica Molecolare "Luigi Luca Cavalli-Sforza", CNR, 27100, Pavia, Italy.
Laura Zannini *Istituto di Genetica Molecolare "Luigi Luca Cavalli-Sforza", CNR, 27100, Pavia, Italy. laura.zannini@igm.cnr.it.
Miriana Cardano *Istituto di Genetica Molecolare "Luigi Luca Cavalli-Sforza", CNR, 27100, Pavia, Italy. miriana.cardano@igm.cnr.it.ORCID http://orcid.org/0000-0001-5027-1309
Istituto di Genetica Molecolare · ITFondazione IRCCS Istituto Nazionale dei Tumori · IT

Funding

Fondazione AIRC per la ricerca sul cancro ETS IG 2018 - ID. 21535
6 · The paper itself

Abstract

backgroundSexual dimorphism represents a key concept in the comprehension of molecular processes guiding several sex-specific physiological and pathological mechanisms. It has been reported that genes involved in many disorders show a sex-dependent expression pattern. Moreover, the loss of Y chromosome (LOY), found to be a physiological age-driven phenomenon, has been linked to many neurodegenerative and autoimmune disorders, and to an increased cancer risk. These findings drove us towards the consideration that LOY may cause the de-regulation of disease specific networks, involving genes located in both autosomal and sex chromosomes.

resultsExploiting the CRISPR/Cas9 and RNA-sequencing technologies, we generated a Y-deficient human cell line that has been investigated for its gene expression profile. Our results showed that LOY can influence the transcriptome displaying relevant enriched biological processes, such as cell migration regulation, angiogenesis and immune response. Interestingly, the ovarian follicle development pathway was found enriched, supporting the female-mimicking profile of male Y-depleted cells.

conclusionThis study, besides proposing a novel approach to investigate sex-biased physiological and pathological conditions, highlights new roles for the Y chromosome in the sexual dimorphism characterizing human health and diseases. Moreover, this analysis paves the way for the research of new therapeutic approaches for sex dimorphic and LOY-related diseases.

Indexed as

CRISPR/Cas9RNA-sequencingSex differencesTranscriptomeY chromosome

Identifiers

PMID38291538
PMCPMC10829266
OpenAlexW4391338920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.